预测胎儿生长受限妊娠不良围产结局的指数
该回顾性研究纳入875例符合ISUOG胎儿生长受限标准的单胎妊娠,开发并验证了由7项临床因素构成的预测指数,用于预测不良围产结局。验证组AUC为0.88(95%CI 0.84-0.92),低风险评分(≤2)阴性预测值85%,高风险评分(≥10)阳性预测值96%。
要点
- 预测指数含7项因素:妊娠期高血压疾病+8分、慢性高血压+4分、孕龄≤32周+5分、脐动脉舒张末期血流缺失或反向+8分、孕前BMI≥35 kg/m²+3分、孤立性腹围<第3百分位-4分、非西班牙裔黑人-2分。
- 验证组AUC为0.88(95%CI 0.84-0.92),与开发组AUC 0.86(95%CI 0.82-0.89)相似(P=0.34)。
- 低风险评分(≤2)占40%,阴性预测值85%(95%CI 81-88%),阴性似然比0.21(95%CI 0.16-0.27)。
核心结论
- 由7项临床因素构成的简易指数可预测不良围产结局,可能有助于符合ISUOG胎儿生长受限标准妊娠的咨询和管理。
研究设计与样本
- 回顾性分析,单中心三级医疗中心2010年11月至2020年8月连续纳入875例符合ISUOG胎儿生长受限标准的单胎无畸形妊娠,随机分为开发集(三分之二)和验证集(三分之一),采用回归分析构建β系数加权指数。
诊断标准与关键数值
- 复合不良围产结局包括围产期死亡、III-IV级脑室内出血、脑室周围白质软化、癫痫、缺氧缺血性脑病、坏死性小肠结肠炎、败血症、支气管肺发育不良及新生儿重症监护病房住院>7天;验证组AUC 0.88(95%CI 0.84-0.92);低风险评分≤2的阴性预测值85%(95%CI 81-88%)、阴性似然比0.21(95%CI 0.16-0.27);高风险评分≥10的阳性预测值96%(95%CI 93-98%)、阳性似然比27.36(95%CI 14.33-52.23)。
临床应用与阅片要点
- 该指数基于胎儿生长受限诊断时即可获取的临床因素,可用于风险分层:低风险评分(≤2)者不良围产结局可能性较低,高风险评分(≥10)者可能性很高;中间风险评分者中50%发生复合不良围产结局。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop and validate an index predictive of adverse perinatal outcome (APO) in pregnancies meeting the consensus-based criteria for fetal growth restriction (FGR) endorsed by the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG).
METHODS: This was a retrospective analysis of consecutive singleton non-anomalous gestations meeting the ISUOG-endorsed criteria for FGR at a single tertiary care center from November 2010 to August 2020. The dataset was divided randomly into a development set (two-thirds) and a validation set (one-third). The primary composite APO comprised one or more of: perinatal demise, Grade III-IV intraventricular hemorrhage (IVH), periventricular leukomalacia (PVL), seizures, hypoxic ischemic encephalopathy (HIE), necrotizing enterocolitis (NEC), sepsis, bronchopulmonary dysplasia (BPD) and length of stay in the neonatal intensive care unit (NICU) > 7 days. Regression analysis incorporated clinical factors readily available at the time of FGR diagnosis. The sum of β coefficient-based weights yielded an index score, the performance of which was assessed in the validation set. Score cut-offs were selected to identify 'high-risk' and 'low-risk' ranges for which positive (PPV) and negative (NPV) predictive values and positive (LR+) and negative (LR-) likelihood ratios were calculated.
RESULTS: Of the 875 consecutive pregnancies that met the criteria for FGR and were included in the study cohort, 405 (46%) were complicated by one or more components of the composite APO, including 54 (6%) perinatal deaths, 22 (3%) neonates with Grade III-IV IVH and/or PVL, nine (1%) with seizures and/or HIE, 91 (10%) with BPD, 57 (7%) with sepsis, 21 (2%) with NEC, and 361 (41%) who remained in the NICU > 7 days. In addition, 270 (31%) pregnancies were delivered by Cesarean section for non-reassuring fetal status, 43 (5%) were admitted to the NICU for < 7 days, 79 (9%) had 5-min Apgar score < 7, 125/631 (20%) had a cord gas pH ≤ 7.1 and 35/631 (6%) had a base excess ≥ 12 mmol/L. The predictive index we developed included seven factors available at the time of FGR diagnosis: hypertensive disorder of pregnancy (HDP) (+8 points), chronic hypertension without HDP (+4 points), gestational age ≤ 32 weeks (+5 points), absent or reversed end-diastolic flow in the umbilical artery (+8 points), prepregnancy body mass index ≥ 35 kg/m2 (+3 points), isolated abdominal circumference < 3rd percentile (-4 points) and non-Hispanic black race (-2 points). The bias-corrected bootstrapped (1000 replicates) area under the receiver-operating-characteristics curve (AUC) of the predictive index for composite APO in the validation group was 0.88 (95% CI, 0.84-0.92), which was similar to that in the development group (AUC, 0.86 (95% CI, 0.82-0.89); P = 0.34). In the total cohort, 40% of pregnancies had a low-risk index score (≤ 2), associated with a NPV of 85% (95% CI, 81-88%) and a LR- of 0.21 (95% CI, 0.16-0.27), and 23% had a high-risk index score (≥ 10), associated with a PPV of 96% (95% CI, 93-98%) and a LR+ of 27.36 (95% CI, 14.33-52.23). Of the remaining pregnancies that had an intermediate-risk score, 50% were complicated by composite APO.
CONCLUSION: An easy-to-use index incorporating seven clinical factors readily available at the time of FGR diagnosis is predictive of APO and may prove useful in counseling and management of pregnancies meeting the ISUOG-endorsed criteria for FGR. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Powel JE, Zantow EW, Bialko MF, et al. Predictive index for adverse perinatal outcome in pregnancies complicated by fetal growth restriction. Ultrasound Obstet Gynecol. 2023. PMID: 36856169. doi:10.1002/uog.26044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。